MedTrace Logo

Macroalgae Consumption - a Pilot Study

NCT05940727 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2023-07-11

No results posted yet for this study

Summary

In this study, the aim is to investigate the food safety of macroalgae. There will be an analysis of macroalgae products for the concentration of cadmium, inorganic arsenic, and iodine in macroalgae, as well as measure the status of these elements in consumers. An investigation of the thyroid function of macroalgae consumers and the use of metabolomics to explore which biological changes occur when consuming seaweed and kelp and when the consumer excludes macroalgae from their diet will be performed.

Conditions

  • Iodine Toxicity

Interventions

OTHER

Habitual macroalgae consumption

The participant have a habitual macroalgae consumption at baseline.

OTHER

No macroalgae consumption

The participants exclude any macroalgae products from their diet

Sponsors & Collaborators

  • Institute of Marine Research

    collaborator OTHER

  • University of Bergen

    lead OTHER

Principal Investigators

  • Inger Aakre, PhD · Institute of Marine Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-15
Completion
2023-01-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940727 on ClinicalTrials.gov